Name (Synonyms) | Correlation | |
---|---|---|
drug1105 | Hydroxychloroquine Sulfate + Azithromycin Wiki | 1.00 |
drug1103 | Hydroxychloroquine Sulfate Wiki | 0.28 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.09 |
D007239 | Infection NIH | 0.06 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This is a randomized controlled trial of the efficacy and safety evaluation of oral administration of Bromhexine hydrochloride for the prevention of SARS-CoV-2 infection and COVID-19 disease in medical personnel assisting patients with a new coronavirus disease
Description: Negative PCR of SARS-CoV-2 and the absence of clinical manifestations of COVID-19 infection in individuals taking Bromhexine hydrochloride 4 weeks after randomization.
Measure: Polymerase chain reaction (PCR) Time: 4 weeks after randomizationDescription: Time to clinical symptoms of a respiratory infection with positive PCR SARS-CoV-2
Measure: Time to symptoms Time: 14 days after last contactDescription: Time to detect positive SARS-CoV-2 PCR
Measure: Time to positive PCR Time: 14 days after last contactDescription: The number of asymptomatic cases of SARS-CoV-2 infection
Measure: Number of cases Time: 14 days after last contactDescription: The number of mild, moderate and severe forms of the disease COVID-19 with Bromhexine hydrochloride
Measure: Case severity Time: 14 days after last contactDescription: Evaluation of adverse events
Measure: Drug tolerance Time: 14 days after last contact